This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Imbruvica
  • /
  • Safety and Efficacy of PCI-32765 in Participants W...
Clinical trial

Safety and Efficacy of PCI-32765 in Participants With Relapsed/Refractory Mantle Cell Lymphoma (MCL) (PCYC-1104-CA)

Read time: 4 mins
Last updated:1st Feb 2011
Source: Clinical Trials
Identifier: NCT01236391
Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest